MLV & Co. in $25M ATM with Anthera Pharmaceuticals

Print More

ANTHAnthera Pharmaceuticals (ANTH) has secured up to $25 million in an ATM (At the Market) transaction with MLV & Co.

The purchase price is the prevailing market price at the time of the Draw Down Notice.

Placement Agent counsel was LeClairRyan, and issuer counsel was Goodwin Procter.

See the PlacementTracker Deal Summary.

Comments are closed.